Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

BCT launched in U.S.

Aug. 16, 1996

Bard to comarket ProstaScint with Cytogen

Aug. 16, 1996

White Iris leukocyte differential analyzer cleared for U.S. market

Aug. 9, 1996

OncorMed to offer genetic testing for BRC2 mutations

Aug. 9, 1996

BRACAone undergoes beta-site testing in U.S.

Aug. 9, 1996

Cyogen's ProstaScint on its way to FDA approval

July 26, 1996

Oncor obtains license to p43 blood test for early-stage breast cancer

July 26, 1996

ICD grants exclusive rights of DR-70 to Y.H. BioTek

July 26, 1996

Quidel's QuickVue Chlamydia Test approved in Germany

July 26, 1996

Contrast agents and antidotes described by Schering AG

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...